ArticleThe oncologist2025

Correlation of TROP2 expression with clinico-pathological features and outcomes in HR+/HER2- breast cancer receiving neoadjuvant chemotherapy.

Hagar Elghazawy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.